Read More Details
Finally We wish PressBee provided you with enough information of ( Evofem Announces Completion of Last Subject Last Visit (LSLV) in Registrational Phase 3 "EVOGUARD" Trial Evaluating Phexxi® for the Prevention of Chlamydia and Gonorrhea in Women )
Also on site :
- Russia reliable partner to Africa in strengthening sovereignty – Lavrov
- Ship carrying oil and hazardous cargo sinks off Kerala coast
- Trysull and Seisdon WI enjoy art workshop